Heart Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are in hospital mainly because of a worsening of their chronic heart failure (CHF)
- People who are medically stable enough to understand and agree to take part in the study
- People who do not have severe memory or thinking difficulties that would make completing questionnaires unreliable
Who may not be able to join:
- People whose hospital admission is for a sudden, new episode of acute heart failure (rather than a worsening of chronic heart failure) (confirm with trial site)
- People whose total hospital stay is less than 96 hours (4 days)
- People who have not had a heart ultrasound (echocardiogram) in the past 12 months and do not have one planned during their stay
- People with severe vision problems that would prevent them from completing the visual sections of a standard memory and thinking test
- People who do not wish to take part in the study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Andrius Ališauskas, MD, PhD, Lithuanian University of Health Sciences
Phone: +37060379771
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
In-hospital all-cause mortality; In-hospital MACE; Number of Participants with chronic heart failure-related rehospitalization
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.